Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Global Core Clinical Molecular Diagnostics Market Size study, by Product Type (Instruments, Reagents, Software & Services), by Technique (PCR, Nucleic Acid Sequencing, Fluorescence In Situ Hybridization (FISH), Others), by Application (Infectious Diseases, Genetic Disorders, Cancer Screening, Others), and Regional Forecasts 2022-2032
... Screening, Others), and Regional Forecasts 2022-2032 The Global Core Clinical Molecular Diagnostics Market is valued at approximately USD 5.26 billion in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global CAR T-Cell Therapy for Multiple Myeloma Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... size was valued at USD 168.7 million in 2023 and is forecast to a readjusted size of USD 982.2 million by 2030 with a CAGR of 28.6% during review period. CARs are also known as ... Read More
-
Global Breast Cancer Liquid Biopsy Market 2024-2028
... 18.06% during the forecast period. The report on the breast cancer liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 ... Read More
-
Global Oncology Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Cancer Diagnostics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Breast Cancer Monoclonal Antibodies Market 2024-2028
... on the breast Cancer monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Decentralised Clinical Trials Market Size Study, by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Immunology, Respiratory, Others), by Component (Mobile Healthcare, Telemedicine, Wearable Devices, Web-based Technology, Others), by End-users (Pharmaceutical and Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032
... Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032 Global Decentralised Clinical Trials Market is valued at approximately USD 9.30 billion in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Non-small Cell Lung Cancer Drugs Market 2024-2028
... The report on the non-small cell lung cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Hairy Cell Leukemia Therapeutics Market 2024-2028
... on the hairy cell leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Bladder Cancer Treatment Drugs Industry Forecasts - China Focus
... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More
-
Bladder Cancer Treatment Drugs Companies in China
... The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other ... Read More
-
Cancer Treatment Drugs Markets in China
... Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's ... Read More
-
Cancer Cachexia Global Market Report 2024
... Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA Cancer Cachexia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2024
... Assays3) By Therapeutic Area: Lung Cancer; Breast Cancer; MelanomaCovering: Thermo Fisher Scientific Inc.; Danaher Corporation; Laboratory Corporation of America Holdings (LabCorp); Eurofins Scientific SE; WuXi AppTec Co Ltd. Cancer Immunotherapy Drug Discovery Outsourcing Global Market ... Read More
-
Cancer Treatment Drugs Industry Forecasts - China Focus
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
Cancer Treatment Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Bladder Cancer Treatment Drugs Markets in China
... grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study ... Read More
-
Global Multiple Myeloma Drugs Market 2024-2028
... multiple myeloma drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Cancer Immunotherapy Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Application (Cancer, Neurodegenerative Disorders), Source (Bone Marrow, Mesenchymal Stem Cells), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Growth & Trends The global autologous cell therapy market size is expected to reach USD 17.97 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand ... Read More
-
Liver Cancer Drugs
... by 2030, growing at a CAGR of 18.4% over the analysis period 2023-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$5.1 Billion ... Read More
-
T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type (Peripheral, Lymphoblastic), By Therapy (Radiotherapy, Immunotherapy, Stem Cell Transplantation), By Region, And Segment Forecasts, 2024 - 2030
... global T-cell lymphoma market size is anticipated to reach USD 3.70 billion by 2030, expanding at a CAGR of 8.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. The ... Read More
-
Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Breast Biopsy Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$983.4 Million ... Read More
-
Melanoma Therapeutics
... at a CAGR of 13.8% over the analysis period 2023-2030. Cutaneous Melanoma Therapeutics, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$4.3 Billion by the end ... Read More
Research Assistance
